Related Experiment Videos
Special conference on 'growth factors, development and cancer
1Istituto Mario Negri, Milan, Italy.
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Available evidence and new biological perspectives on medical treatment of advanced thymic epithelial tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Genetic markers for prediction of treatment outcomes in ovarian cancer.
The pharmacogenomics journal·2014
Seminars in clinical pharmacology: an introduction to MET inhibitors for the medical oncologist.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
RAS/RAF/MEK inhibitors in oncology.
Current medicinal chemistry·2012
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Margin-enriched CD4+ central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma.
International journal of biological sciences·2026
Mapping the Evolutionary Landscape of Solid Tumor Immunotherapy: A Quarter-Century Bibliometric Analysis of the Title-Defined Core Literature (2000-2025).
International journal of medical sciences·2026
Decoding Pancreatic Cancer Pain: From Tumor-Nerve Crosstalk to Targeted Analgesic Strategies.
International journal of medical sciences·2026
Urinary microbiota in bladder cancer: insights into pathogenesis, diagnosis, and therapeutic potential.
Frontiers in cellular and infection microbiology·2026
Obstructive Sleep Apnoea and Atrial Fibrillation: Current Evidence and Emerging Research Directions.
Reviews in cardiovascular medicine·2026
The subcellular localization-dependent dual role of NR4A1 in renal fibrosis: mechanisms and therapeutic perspectives.
Frontiers in pharmacology·2026